AP protocol 2 - CISMeF

Preferred Label : AP protocol 2;

MeSH note : chemotherapy protocol consisting of above compounds; used in treatment of multiple myeloma;

CISMeF synonym : AP combination; MP protocol;

MeSH synonym : MPH-P protocol;

Is substance : O;

Détails

Origin ID

C034854;

UMLS CUI

C0284383;

Automatic exact mappings (from CISMeF team)
- Angina pectoris [ICD-11 Category]
- Glycosaminoglycan [FMA entity]
- Glycosaminoglycans [LOINC component]
- Hyperplastic Polyp [NCIt concept]
- Melphalan/Prednisone [NCIt concept]
- Musical perfect pitch [OMIM Phenotype]
- Personal Medical History [NCIt concept]
- Pulmonary arterial trunk [FMA entity]
- Pulmonary artery [FMA entity]
- Pulmonary trunk [FMA entity]
- mucopolysaccharide, nos [SNOMED Notion]
Currated CISMeF NLP mapping
- Melphalan/Prednisone Regimen [NCIt concept]
False automatic mappings
- Antiphospholipid syndrome [ORDO Disease]
MeSH term(s) associated for indexing
- antineoplastic combined chemotherapy protocols [MeSH Descriptor]
- melphalan [MeSH Descriptor]
- prednisone [MeSH Descriptor]
Ne pas confondre avec
- AP protocol 1 [MeSH Supplementary Concept]
Record concept(s)
- AP combination [MeSH concept]
- AP protocol 2 [MeSH concept]
- MP protocol [MeSH concept]
Semantic type(s)
- Therapeutic or Preventive Procedure [UMLS semantic type]
UMLS correspondences (same concept)
- Melphalan/Prednisone [NCIt concept]

Position du mot-clé dans l'(les) arborescence(s) :

Vous pouvez consulter :

recommendations
documents concerning education
documents for patients